Ranbaxy Wins U.S. Approval for Generic Diovan for Heart

Ranbaxy Laboratories Ltd. surged to an 18-month high in Mumbai trading after winning U.S. approval to make Novartis AG 's blood pressure drug Diovan almost two years after the $3.5 billion medicine lost patent protection.

http://ift.tt/1jSV5bJ